Detection of myocardial medium‐chain fatty acid oxidation and tricarboxylic acid cycle activity with hyperpolarized [1–13C]octanoate

Under normal conditions, the heart mainly relies on fatty acid oxidation to meet its energy needs. Changes in myocardial fuel preference are noted in the diseased and failing heart. The magnetic resonance signal enhancement provided by spin hyperpolarization allows the metabolism of substrates labeled with carbon‐13 to be followed in real time in vivo. Although the low water solubility of long‐chain fatty acids abrogates their hyperpolarization by dissolution dynamic nuclear polarization, medium‐chain fatty acids have sufficient solubility to be efficiently polarized and dissolved. In this study, we investigated the applicability of hyperpolarized [1–13C]octanoate to measure myocardial medium‐chain fatty acid metabolism in vivo. Scanning rats infused with a bolus of hyperpolarized [1–13C]octanoate, the primary metabolite observed in the heart was identified as [1–13C]acetylcarnitine. Additionally, [5‐13C]glutamate and [5‐13C]citrate could be respectively resolved in seven and five of 31 experiments, demonstrating the incorporation of oxidation products of octanoate into the tricarboxylic acid cycle. A variable drop in blood pressure was observed immediately following the bolus injection, and this drop correlated with a decrease in normalized acetylcarnitine signal (acetylcarnitine/octanoate). Increasing the delay before infusion moderated the decrease in blood pressure, which was attributed to the presence of residual gas bubbles in the octanoate solution. No significant difference in normalized acetylcarnitine signal was apparent between fed and 12‐hour fasted rats. Compared with a solution in buffer, the longitudinal relaxation of [1–13C]octanoate was accelerated ~3‐fold in blood and by the addition of serum albumin. These results demonstrate the potential of hyperpolarized [1–13C]octanoate to probe myocardial medium‐chain fatty acid metabolism as well as some of the limitations that may accompany its use.

[1]  A. Sherry,et al.  Metabolism of hyperpolarized 13C‐acetoacetate to β‐hydroxybutyrate detects real‐time mitochondrial redox state and dysfunction in heart tissue , 2019, NMR in biomedicine.

[2]  G. Radda,et al.  A new hyperpolarized 13C ketone body probe reveals an increase in acetoacetate utilization in the diabetic rat heart , 2019, Scientific Reports.

[3]  D. Abdurrachim,et al.  Empagliflozin reduces myocardial ketone utilization while preserving glucose utilization in diabetic hypertensive heart disease: A hyperpolarized 13C magnetic resonance spectroscopy study , 2018, Diabetes, obesity & metabolism.

[4]  R. Tan,et al.  Cardiac metabolic modulation upon low‐carbohydrate low‐protein ketogenic diet in diabetic rats studied in vivo using hyperpolarized 13C pyruvate, butyrate and acetoacetate probes , 2019, Diabetes, obesity & metabolism.

[5]  V. Positano,et al.  Biomolecular imaging of 13C-butyrate with dissolution-DNP: Polarization enhancement and formulation for in vivo studies. , 2018, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[6]  R. Gruetter,et al.  Probing cardiac metabolism by hyperpolarized 13C MR using an exclusively endogenous substrate mixture and photo‐induced nonpersistent radicals , 2018, Magnetic resonance in medicine.

[7]  D. Tyler,et al.  Hyperpolarized ketone body metabolism in the rat heart , 2018, NMR in biomedicine.

[8]  David S. Wishart,et al.  HMDB 4.0: the human metabolome database for 2018 , 2017, Nucleic Acids Res..

[9]  M. Merritt,et al.  Measuring changes in substrate utilization in the myocardium in response to fasting using hyperpolarized [1-13C]butyrate and [1-13C]pyruvate , 2016, Scientific Reports.

[10]  J. Schwitter,et al.  High-field dissolution dynamic nuclear polarization of [1-(13)C]pyruvic acid. , 2016, Physical chemistry chemical physics : PCCP.

[11]  A. Haase,et al.  Metabolic imaging of hyperpolarized [1‐13C]acetate and [1‐13C]acetylcarnitine ‐ investigation of the influence of dobutamine induced stress , 2015, Magnetic resonance in medicine.

[12]  R. Gruetter,et al.  Direct noninvasive estimation of myocardial tricarboxylic acid cycle flux in vivo using hyperpolarized ¹³C magnetic resonance. , 2015, Journal of molecular and cellular cardiology.

[13]  A. Haase,et al.  Investigation of metabolic changes in STZ-induced diabetic rats with hyperpolarized [1-13C]acetate , 2015, Physiological reports.

[14]  V. Positano,et al.  Real-time cardiac metabolism assessed with hyperpolarized [1-(13) C]acetate in a large-animal model. , 2015, Contrast media & molecular imaging.

[15]  M. Merritt,et al.  Hyperpolarized Magnetic Resonance as a Sensitive Detector of Metabolic Function , 2014, Biochemistry.

[16]  Y. Yen,et al.  Dynamic metabolic imaging of hyperpolarized [2‐13C]pyruvate using spiral chemical shift imaging with alternating spectral band excitation , 2014, Magnetic resonance in medicine.

[17]  Kieran Clarke,et al.  Hyperpolarized Butyrate: A Metabolic Probe of Short Chain Fatty Acid Metabolism in the Heart , 2013, Magnetic resonance in medicine.

[18]  A. Comment,et al.  Over 35% liquid-state 13C polarization obtained via dissolution dynamic nuclear polarization at 7 T and 1 K using ubiquitous nitroxyl radicals. , 2013, Physical chemistry chemical physics : PCCP.

[19]  B. Brandt,et al.  Automated transfer and injection of hyperpolarized molecules with polarization measurement prior to in vivo NMR , 2013, NMR in biomedicine.

[20]  S. Meier,et al.  Development of Dissolution DNP-MR Substrates for Metabolic Research , 2012 .

[21]  G. Radda,et al.  The Cycling of Acetyl-Coenzyme A Through Acetylcarnitine Buffers Cardiac Substrate Supply: A Hyperpolarized 13C Magnetic Resonance Study , 2012, Circulation. Cardiovascular imaging.

[22]  J. Ardenkjaer-Larsen,et al.  Study of molecular interactions with 13C DNP-NMR. , 2010, Journal of magnetic resonance.

[23]  T. Yanagita,et al.  Medium-chain fatty acids: functional lipids for the prevention and treatment of the metabolic syndrome. , 2010, Pharmacological research.

[24]  C. Folmes,et al.  Myocardial fatty acid metabolism in health and disease. , 2010, Physiological reviews.

[25]  G. Larry Bretthorst,et al.  The Bayesian Analysis Software Developed At Washington University , 2009 .

[26]  S. Meier,et al.  Tissue-specific Short Chain Fatty Acid Metabolism and Slow Metabolic Recovery after Ischemia from Hyperpolarized NMR in Vivo* , 2009, The Journal of Biological Chemistry.

[27]  G. Radda,et al.  Real‐time assessment of Krebs cycle metabolism using hyperpolarized C magnetic resonance spectroscopy , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  C. Des Rosiers,et al.  Medium-chain Fatty Acids as Metabolic Therapy in Cardiac Disease , 2008, Cardiovascular Drugs and Therapy.

[29]  R. Gruetter,et al.  Design and performance of a DNP prepolarizer coupled to a rodent MRI scanner , 2007 .

[30]  M. Thaning,et al.  Real-time metabolic imaging. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Bramahn . Singh,et al.  Metabolic Modulators for Chronic Cardiac Ischemia , 2005, Journal of cardiovascular pharmacology and therapeutics.

[32]  William C Stanley,et al.  Myocardial substrate metabolism in the normal and failing heart. , 2005, Physiological reviews.

[33]  A. Garnier,et al.  Energy metabolism in heart failure , 2004, The Journal of physiology.

[34]  L. Opie,et al.  Glucose and glycogen utilisation in myocardial ischemia - changes in metabolism and consequences for the myocyte , 1998, Molecular and Cellular Biochemistry.

[35]  R. Haller,et al.  Octanoate oxidation measured by 13C-NMR spectroscopy in rat skeletal muscle, heart, and liver. , 2003, Journal of applied physiology.

[36]  Piero Rinaldo,et al.  Fatty acid oxidation disorders. , 2002, Annual review of physiology.

[37]  R Gruetter,et al.  Field mapping without reference scan using asymmetric echo‐planar techniques , 2000, Magnetic resonance in medicine.

[38]  S. Eaton,et al.  Mammalian mitochondrial beta-oxidation. , 1996, The Biochemical journal.

[39]  T. Hashimoto,et al.  Two mitochondrial 3-hydroxyacyl-CoA dehydrogenases in bovine liver. , 1996, Journal of biochemistry.

[40]  A. Sherry,et al.  A 13C isotopomer n.m.r. method for monitoring incomplete beta-oxidation of fatty acids in intact tissue. , 1994, The Biochemical journal.

[41]  J. Hamilton,et al.  13C NMR studies of the binding of medium-chain fatty acids to human serum albumin. , 1994, Journal of lipid research.

[42]  P. Ekwall.  Solutions of alkali soaps and water in fatty acids XI. Correlation between the acid sodium octanoate in the most water-rich part of the L2-phase and the acid soaps in two adjacent phases , 1988 .

[43]  D. Cistola,et al.  Interactions of myristic acid with bovine serum albumin: a 13C NMR study. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[44]  T. Hashimoto,et al.  The presence of a new 3-oxoacyl-CoA thiolase in rat liver peroxisomes. , 1980, European journal of biochemistry.

[45]  D. Deamer,et al.  Liposomes from ionic, single-chain amphiphiles. , 1978, Biochemistry.

[46]  T. Drakenberg,et al.  13C NMR of micellar solutions , 1973 .

[47]  D. Doddrell,et al.  Segmental motion in liquid 1-decanol. Application of natural-abundance carbon-13 partially relaxed Fourier transform nuclear magnetic resonance , 1971 .

[48]  J. McGarry,et al.  The regulation of ketogenesis from octanoic acid. The role of the tricarboxylic acid cycle and fatty acid synthesis. , 1971, The Journal of biological chemistry.

[49]  J. Schrezenmeir,et al.  Medium chain Triglycerides , 1969, Drug and therapeutics bulletin.

[50]  D. Pearson,et al.  Carnitine and derivatives in rat tissues. , 1967, The Biochemical journal.

[51]  C. Wycoff,et al.  Experimental pulmonary air embolism in dogs. , 1966, California medicine.